Download Current Issue (PDF)
Clues to fighting cancer are being revealed through genomic analysis, which looks at the DNA of cancer cells for mutations to target. A new Genomics Tumor Board at MUSC hopes to outwit "smart" cancers.
Hollings has received an $8.9 million grant to foster collaboration across clinical and laboratory research for the study of signaling in sphingolipids, a class of lipids involved in the growth of solid tumor cancers.
See recent peer-reviewed publications from HCC physicians, researchers and postdoctoral trainees.